Event title Romanian drug industry - factor of economic recovery or collateral victim of health care reform?

Event argument

In the last years there has been a strong tendency of decreasing market share of locally produced drugs. Late payments, a suffocating fiscal framework and a lack of direct recognition from the authorities of the contribution of this sector to economic growth have reduced the investment in new production facilities.

Drugs that are produced in Romania are, mostly, generic drugs. Despite the fact that generics are, in most European Union countries, a primary driver of cost efficiency of the health system and ensuring a broad access of population to medication, Romanian authorities have supported the use of generics more declarative. New health reform talks too little, if any, of local and generic manufacturers as a solution to efficient health system. Conference organized in partnership with ZF APMGR aims to answer some critical questions for future drug Romanian industry. Romania has a drug industry? Can it contribute to the economic recovery? What are the facilities that the state may provide for the opening of new production capacities? Generics can be a solution for relocation on a sustainable health system? How can the state and industry support drug education recovery in this sector with high added value? Format of the event

Conference to be attended by representatives of the Ministry of Health, the National House of Health, Ministry of Finance, Government, other authorities, representatives of the business press. Debates 1. General economic context and the evolution of the Romanian market of drugs, analysis Romanian manufacturers of medicines who are producing and what evolution had in recent years; 2. Exports and the contribution that Romanian producers of drugs they have the trade balance; 3. What forms of domestic prices for drugs; 4. Trends and growth opportunities for local manufacturers of drugs; 5. Investments drug makers: how, what and where their "place" money; 6. Cash management in the drug industry; 7. Legislation and challenges for drug manufacturers; 8. State Vs. drug industry: encouraging the opening of new facilities production capacity in Romania, encouraging the use of generic, national policy?

9. State and Romanian producers of drugs: partnership for a school profile; Possible speakers : Health Minister / Secretary of State; President of the National House of Santa / CEO; Director Ministry of Finance; Prime Minister / Representative of the Government; Presidents / CEOs of manufacturers; Representative - Medical College of Romania; Representative - College of Pharmacists in Romania; Leaders of the business environment; Analysts. Participants: Leaders of member companies of the Association of Producers of generics in Romania (APMGR), authorities, leaders of the business environment, the press.